|
HS Code |
614199 |
| Name | (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine |
| Synonyms | (R)-(-)-N-(3,5-Dinitrobenzoyl)-1-phenylethylamine |
| Cas Number | 115403-48-4 |
| Molecular Formula | C15H13N3O5 |
| Molecular Weight | 315.28 |
| Appearance | Pale yellow to yellow solid |
| Purity | Typically ≥98% |
| Optical Rotation | [α]D20 -94° to -98° (c=1, CHCl3) |
| Solubility | Soluble in organic solvents (e.g., dichloromethane, chloroform) |
| Melting Point | 149-152°C |
| Storage Conditions | Store at 2-8°C, protected from light |
| Chirality | R-configuration |
| Application | Chiral resolution reagent |
As an accredited (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle sealed with a screw cap, labeled clearly, containing 5 grams of (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine. |
| Shipping | Shipping of (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine is conducted in compliance with chemical safety regulations. The compound is securely packaged in airtight, labeled containers to prevent leakage or contamination. It is transported under controlled environmental conditions, with all necessary documentation and hazard information provided for safe handling and delivery. |
| Storage | (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers and reducing agents. Protect it from light and moisture. Store at room temperature and avoid sources of ignition. Label the container clearly and ensure appropriate safety measures are in place during handling. |
Applications of (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine in Industrial ManufacturingAs an original manufacturer, we supply (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine as a proven chiral selector and resolving agent across advanced process routes in the pharmaceutical and fine chemical sectors. The following sections describe real-world downstream industrial uses, with specific production and compliance data outlining integration into customer operations. 1. Chiral Resolution in Active Pharmaceutical Ingredient (API) ManufacturingOur material enables precise enantioselective separation of pharmaceutical intermediates critical for API manufacturing, especially in β-blockers, antihistamines, and certain CNS agents. By forming diastereomeric salts with racemic amine compounds, downstream partners achieve high optical purity essential for regulatory review. Usage runs under strict cGMP controls, with documented control over enantiomeric excess and impurity profiles. We maintain validated supply protocols meeting international regulatory audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Stereoselective Synthesis in Agrochemical Intermediates ProductionProducers of agrochemical intermediates utilize this compound for enantiomeric separation, targeting high-value chiral building blocks for herbicides and fungicides with improved biological profiles. Downstream integration typically follows intermediate reaction phases where isolation of single-enantiomer precursors feeds into selective synthetic steps. Industrial application demands process-verified residue removal, validated impurity control, and batch traceability for audit trail assurance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Analytical Chiral Standards ManufacturingManufacturers of analytical reference standards employ this product as a resolving agent in setting chiral purity benchmarks for HPLC, GC, and SFC analytical systems. The separation process at reference material facilities follows method validation protocols, ensuring preparation of calibration-grade chiral standards for industrial and regulated analytical laboratories worldwide. Our production aligns with traceability and documentation requirements for metrological supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemicals Sector: Synthesis of Optical Resolution Auxiliary AgentsSpecialty chemical manufacturers incorporate this resolving agent in the scalable production of auxiliary chiral compounds, used as building blocks and support reagents. These applications support the preparation of ligands, auxiliaries, and catalysts needed for advanced synthesis in both research and bulk manufacturing. Strict documentation, impurity profiling and batch-wise verification form core compliance requirements for global distribution. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
After decades in chemical manufacturing, I tend to greet each substance with a mix of respect and curiosity. Take (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine—an unusual name, sure, but those who handle chiral derivatizing agents in the lab know this compound by its unique role and unmistakable properties. What sets this material apart comes down to the pure hands-on chemistry that shapes its value in both research and industrial settings.
The story starts at the bench, not the boardroom. Manufacturing (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine begins with premium-grade raw materials; the quality of these starting compounds is the backbone of the output. In our own experience, we have seen subtle differences in purity come through immediately at the crystallization stage. A sharp, bright crystalline material emerges only with diligent control over temperature gradients and solvent purity. Those slight traces of yellowing or clumping point to overlooked impurities. Such issues, though minor on paper, cast ripples deep into the end-use—especially in chiral resolution, where even negligible contamination can twist and muddle results beyond recognition.
Over time, we favored continuous improvement and close observation. The manufacturing process for this compound—without sharing proprietary techniques—uses carefully calibrated steps for acylation, followed by exhaustive purification sequences. The product takes shape as a colorless or faintly yellow crystal, boasting high optical purity and chemical stability. The differentiator here is not a marketing claim, but the result of thousands of chromatographic tests: consistently replicable enantiomeric excess, a clean NMR spectrum, and a melting point range that doesn’t drift batch to batch. There are no shortcuts that can substitute for this kind of consistency.
Ask a synthetic chemist about amino acid analysis, and you’ll likely hear about Marfey’s reagent, Mosher’s acid, and a handful of specialty derivatives. (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine is another essential tool. Instead of abstract promises about versatility, I want to speak directly to its real-world strengths—what makes it a regular fixture in our customers’ chromatography suites.
This compound provides a powerful route to separations based on enantiomeric purity. In practice, the amine group easily forms stable derivatives with a wide array of carboxylic acids and esters, generating diastereomers with distinct physical properties. Chiral resolution using this agent simplifies the analysis down to clear, unambiguous peaks in both HPLC and GC traces. Other reagents sometimes produce partially overlapping peaks, hinting at incomplete reactions or instability under mild hydrolysis. We have seen clear advantages in robustness during aqueous workups, with reduction in side-product formation even under basic or mildly acidic extraction protocols.
Researchers often need to compare the performance of different chiral auxiliaries in the same system. In our chemical pilot line, side-by-side evaluations with other benzoylated chiral amines show (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine offering greater thermal stability and extended shelf-life. Unlike similar agents, which tend to degrade from minute exposure to moisture, our product retains composition and performance for over a year when stored correctly. The crystalline nature means it rarely cakes or becomes oily at room temperature, so weighing and handling remain hassle-free—even after months in the storage cabinet. This practical edge isn’t always obvious until you have to repeat a reaction for reproducibility: every time, the physical integrity and reactivity hold up.
Purity standards in academic research and pharma development have grown especially strict. Researchers share feedback that even slight differences between supplied batches can disrupt their calibration standards, so we prioritize consistency. Every batch of (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine goes through chiral HPLC and TLC screening, with random checks for residual solvents or unreacted precursors. Typical specifications show optical rotation tightly matching literature values, with single-digit ppm levels of any byproducts. Reflecting on decades at the plant, I know firsthand that shortcuts on quality control never save money—they just eat up time during customer troubleshooting, slowing down discovery or production runs.
We’ve also worked alongside many analytical chemists running routine chiral resolution studies. One shared story involved troubleshooting a persistent broadening of HPLC peaks. After comparing reagents from multiple sources, it turned out that subpar drying in the final manufacturing step brought in excess moisture. Our protocol calls for a two-stage drying process—first at vacuum at low heat, then a final shelf desiccation for 48 hours. It takes more time, and it slows down throughput, but it directly prevents hydration spots and delivers crystals that dissolve easily in both protic and aprotic solvents.
Reading technical documents, you’ll find endless columns of melting points and solubilities. Out on the floor, what matters more is how the product behaves from jar to reactor. (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine creates meaningful time savings with straightforward dissolution, reducing the need for extended sonication or pre-warming. The granularity of the crystal crop means less static, less clumping, and a smoother transfer at the bench. Less time spent digging material out of a sticky bottle or breaking up clumps means more data in the book and better record-keeping for the entire lab team.
Scalability stands as another deciding factor. Many chiral auxiliaries, while effective at milligram scale, come with severe handling pain points when moving up to multi-gram synthesis. Our product packs reliably for both small-scale and batch-scale production. The uniform appearance and traceability from batch labels turn the focus back to experiment outcomes, not error chasing. On larger runs, waste minimization also comes into play. Overdosing a less-pure enantiomer eats up dollars quickly in pharmaceutical screening, or worse, introduces variable bioactivity in test batches. Conversations with downstream partners in pharma R&D always circle back to this: high, reliable purity controls cost and reduces risk. In a world of tightening audits, trace metals, and unexplained out-of-spec readings, (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine earns respect through predictability.
Chemists love side-by-side comparisons more than most, and the landscape for chiral amine derivatives is crowded. The starkest contrast emerges between our compound and more common N-benzoyl or N-tosyl alpha-phenylethylamines. Laboratory data and direct use cases highlight where the nitro groups on the 3 and 5 positions pull electron density, which enhances both stability and reactivity when forming derivatives. This means sharper separations and cleaner crudes, especially when resolving racemic carboxylates or amides. From a safety standpoint, unlike sulfonyl derivatives, our dinitrobenzoyl amine generates no toxic gas or aggressive byproduct upon mild hydrolysis.
Milder synthetic methods also benefit. Researchers regularly request insight on which chiral amine delivers the most reliable yield in low-temperature or solvent-restricted processes. The specific electronic configuration and crystallinity of (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine allow for greater procedural margin. Air-sensitive reactions that falter with more labile auxiliaries run without hiccup, even with less than pristine atmospheric controls. This edge traces back to subtle aspects of the synthesis: by keeping the final product as free from low-molecular-weight contaminants as possible, intervening reactions show less byproduct masking and allow for more straightforward post-reaction purification—a welcome relief for process chemists battling through multi-step sequences.
Few things inform manufacturing choices better than direct conversations with advanced users. One research team pointed out that, with other chiral benzamide derivatives, repeated attempts to scale from bench to kilo-lab failed due to waxy, impure intermediates choking out separation columns. Our product’s uniform granular form prevented this, allowing for clean separations on both silica and basic alumina columns. These insights reach well beyond technical bullet points—they define the day-to-day experience of process chemists. Another long-term customer found that switching to our grade reduced the number of re-crystallization steps by nearly half, directly improving their throughput and freeing up critical reactor time for other projects.
We listen to these stories, channeling them directly into production planning. Batch-to-batch reproducibility isn’t only a question for regulatory paperwork—it underpins a laboratory’s reputation and success over time. Each month, we review outlier feedback and crosscheck both the physical properties and chiral excess results to ensure zero drift creeps into the supply chain. This feedback loop, from benchtop all the way back to batch planning, keeps quality high and error rates at bay.
Modern labs demand ever tighter control, not just on product quality, but on procedural safety. During our audits, there’s an unmistakable trend: labs gravitate toward chemicals with manageable hazard profiles. The production process for (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine incorporates measures that reduce exposure to volatile organic compounds, while our packaging lines feature sealed liners and moisture-absorbent packs—not as an afterthought, but because repeat spills and ruined batches in the past demanded it.
Our technical support team often fields questions on safe long-term handling. Experience highlights that low residual solvent means less concern for fume hood overflow, and lower risk during weighing and dispensing. In one instance, a partner university reported that switching to our compound allowed safe ambient handling instead of burdensome glovebox protocols demanded by other derivatives—reducing both PPE costs and waste streams.
The growth in asymmetric synthesis has shifted these molecules from chemical curiosities to real engines for progress, especially in areas like new drug candidates and agrochemical innovation. In multistep syntheses where each intermediate can become a choke point, (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine acts as a reliable checkpoint. The clarity of the chromatographic output matters as much as the reaction yield because the end-user must trust what they read on the trace, not just what the theoretical procedure promises.
Application scientists report that, for process validation in closely regulated fields, using a chiral auxiliary with both a well-documented synthetic history and proven, reproducible performance streamlines regulatory reviews. In our collaboration with pharmaceutical teams, we’ve seen the emphasis shift from lowest-cost and bulk delivery to deep, auditable paper trails. Retaining every spectral analysis, maintaining years-long certificates of analysis, and logging even the smallest process deviation: these routines separate producers from repackagers. In the end, peace of mind comes only from track record, and ours stands on customer successes and decades of zero recall events related to this compound.
No modern chemical manufacturing can ignore the environmental angle. Our synthesis pathway for (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine was re-engineered over the last decade to remove hazardous chlorinated solvents and to recycle process waste. Water-based washing streams are neutralized and monitored before disposal. These steps grow out of both regulatory duty and shared professional pride: everybody on the factory floor, and in the laboratories we serve, knows waste streams threaten more than just profits.
Emissions control and reduced energy profile for the synthesis are ongoing priorities. Installation of closed-loop chillers and updated filtration lines trimmed energy demand and limited thermal emissions during the peak summer months. These behind-the-scenes tweaks mean the final product isn’t burdened by legacy environmental shortcuts, making it easier for our clients to meet their own sustainability benchmarks.
Engagement with the research community turns up surprises nearly every season. Academic collaborations and joint publications provide new tests, edge-case scenarios, and open up feedback channels on yet-uncovered uses of our compound. This process doesn’t only improve performance; it keeps us honest. If a new analytical method discovers weak spots in our material, we regroup and refine, driven not by marketing calls, but by pride in technical achievement. Our best innovation comes out of these challenges, not from resting on reputation.
We view (R)-(-)-N-(3,5-Dinitrobenzoyl)-Alpha-Phenylethylamine less as another line item in a vast chemical catalogue and more as a reflection of our craft. Precision in its manufacture carries over directly to breakthroughs in chiral chemistry, to greater reliability in process validation, and to lasting trust between bench scientists and suppliers alike. There are no universal shortcuts or silver-bullet solutions in chemical manufacturing, only a steady grind toward consistency, transparency, and real utility. Over years, our relationship with this compound—and the professionals who rely on it—steadily shaped every improvement we made. From the production floor to shipment and beyond, we stand behind each batch with the perspective only experience brings.